HBA1c
Last reviewed 07/2023
Glycosylated haemoglobin (Hb A1) measurement is the most widely used measure of longterm glycaemic control in diabetes.
Glycosylated haemoglobin is produced by the non-enzymatic glycosylation of haemoglobin at a rate proportional to the prevailing glucose concentration. The level of Hb A1 depends upon:
- red cell lifespan
- prevailing blood glucose concentration
Providing red cell lifespan is normal, Hb A1 measures mean blood glucose concentration over the preceding 60 days - i.e. half-life of red cell.
Some assays measure total glycosylated haemoglobin whilst others measure Hb A1c produced by glycosylation of the N-terminal valine of the B-chain of haemoglobin.
Notes:
- the HbA1c results will be reported exclusively as mmol/mol of haemoglobin without glucose attached, rather than a percentage as previously, from June 1st 2011
- the International Federation of Clinical Chemistry and Laboratory Medicine
(IFCC) has initiated the change:
- the equivalent of the current DCCT HbA1c targets of 6.5% and 7.5% are 48 mmol/mol and 59 mmol/mol in the new units, with the nondiabetic reference range of 4.0% to 6.0% being 20 mmol/mol to 42 mmol/mol
-
DCCT- HbA1c (%) IFCC-HbA1c (mmol/mol) 6.0 42 6.5 48 7.0 53 7.5 59 8.0 64 9.0 75
reference range (glycosylated haemoglobin)
relationship between glycosylated haemoglobin (HbA1c) and mean plasma glucose
glycosylated haemoglobin (HbA1c) and risk of congenital malformation in diabetes
gycosylated haemoglobin (HbA1c) and haemoglobin variants
glycosylated haemoglobin (HbA1c) and cardiovascular (macrovascular) disease (CVD)
glycosylated haemoglobin (HbA1c) and accuracy as a measure of glycaemia
NICE guidance - glucose control levels
glycosylated haemoglobin (HbA1c) and anaemia
conversion of HbA1c from percentage to mmol/mol glucose
glycosylated haemoglobin (HbA1c) in diagnosis of diabetes
some of the factors that influence HbA1c (glycosylated haemoglobin) and its measurement